[HTML][HTML] Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era

AAS Akil, E Yassin, A Al-Maraghi, E Aliyev… - Journal of translational …, 2021 - Springer
Type 1 diabetes affects millions of people globally and requires careful management to
avoid serious long-term complications, including heart and kidney disease, stroke, and loss …

[HTML][HTML] Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes

SZ Hasnain, JB Prins… - Journal of molecular …, 2016 - jme.bioscientifica.com
The inability of pancreatic β-cells to make sufficient insulin to control blood sugar is a central
feature of the aetiology of most forms of diabetes. In this review we focus on the deleterious …

[HTML][HTML] Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments

Y Feng, T Yang, J Zhu, M Li, M Doyle… - Nature …, 2023 - nature.com
Spatial proteomics technologies have revealed an underappreciated link between the
location of cells in tissue microenvironments and the underlying biology and clinical …

[HTML][HTML] Current progress in stem cell therapy for type 1 diabetes mellitus

S Chen, K Du, C Zou - Stem cell research & therapy, 2020 - Springer
Type 1 diabetes mellitus (T1DM) is the most common chronic autoimmune disease in young
patients and is characterized by the loss of pancreatic β cells; as a result, the body becomes …

The human islet: mini-organ with mega-impact

JT Walker, DC Saunders, M Brissova… - Endocrine …, 2021 - academic.oup.com
This review focuses on the human pancreatic islet—including its structure, cell composition,
development, function, and dysfunction. After providing a historical timeline of key …

Impact of islet architecture on β-cell heterogeneity, plasticity and function

SS Roscioni, A Migliorini, M Gegg… - Nature Reviews …, 2016 - nature.com
Although β-cell heterogeneity was discovered more than 50 years ago, the underlying
principles have been explored only during the past decade. Islet-cell heterogeneity arises …

[HTML][HTML] Generation of pancreatic β cells for treatment of diabetes: advances and challenges

HM Shahjalal, A Abdal Dayem, KM Lim, T Jeon… - Stem cell research & …, 2018 - Springer
Human embryonic stem cells (hESC) and induced pluripotent stem cells (hiPSC) are
considered attractive sources of pancreatic β cells and islet organoids. Recently, several …

Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations

L Antonioli, C Blandizzi, B Csóka, P Pacher… - Nature reviews …, 2015 - nature.com
Adenosine is a key extracellular signalling molecule that regulates several aspects of tissue
function by activating four G-protein-coupled receptors, A1, A2A, A2B and A1 adenosine …

In vivo–mimicking microfluidic perfusion culture of pancreatic islet spheroids

Y Jun, JS Lee, S Choi, JH Yang, M Sander… - Science …, 2019 - science.org
Native pancreatic islets interact with neighboring cells by establishing three-dimensional
(3D) structures, and are surrounded by perfusion at an interstitial flow level. However, flow …

Extracellular Matrix–Associated Factors Play Critical Roles in Regulating Pancreatic β-Cell Proliferation and Survival

SE Townsend, M Gannon - Endocrinology, 2019 - academic.oup.com
This review describes formation of the islet basement membrane and the function of
extracellular matrix (ECM) components in β-cell proliferation and survival. Implications for …